EVFM Evofem Biosciences has a big upcoming catalyst: Its Phase 3 clinical trial evaluating Phexxi for the prevention of chlamydia and gonorrhea in women is on track to report top-line data from this landmark trial in mid-October, so we are one week away from results! Positive study outcomes would enable potential U.S. approval for prevention of these sexually...
$EVFM produces the only FDA approved hormone-free contraceptive & developing products preventing STIs & HIV. Phase 3 trial results coming later this year. High demand for contraceptives after Roe v. Wade was overturned. www.cnn.com
Recent Political stuff added to the crazy bear market , i can see from the indicators a reversal is in progress and will continue! Im not a financial advisor and this is crayons 101 Cheers!
A dramatic sharp increase is expected, recommended for mid-term, growing up to around 30-35.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that,...
Congrats to those that took full advantage of EVFM. The stock closed up 19% on Friday closing the huge gap that I mentioned on May 30th "This penny stock could make a huge move to the upside. Keep it on your watch list. A break of 87c with force might give the stock room to +$1.2". I sold all my shares yesterday.
Evofem Biosciences Inc (NASDAQ:EVFM) was on my list a few days ago, and has been slowly trying to make a move up. Volume starts to pick up again. This penny stock could make a huge move to the upside. Keep it on your watch list. A break of 87c with force might give the stock room to +$1.2
Been watching EVFM for a while now, I am new to chart analysis but wanted to share a few ideas. EVFM recently launched their new product PHEXXI and with that I wonder if it will stimulate the price action with upcoming earnings report. First line of resistance to break is around $2.40 and after that somewhere around 2.70. Any ideas fellas?
September 8 Phexxi release should bring in plenty of buyers, target $4-4.50
One of my favorite chart plays is the gap up play. This hit my radar last week and I plan on starting a small position Monday morning. Also has a solid support line and has been consistently trading inside the pattern. A high volume day and we should see it gap up without any problems.
it might be unrealistic target but nothing is impossible, it might close that gap one day !
we should see $8 before september , hopefully they will do good job after offering
I am not sure exactly when we can see 3 digits for EVFM because of current virus situation BUT this company going to be major player in the birth control market !!!